Whole blood RNA expression profiles in ovarian cancer patients with or without residual tumors after primary cytoreductive surgery

Author：      

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.27, Iss.5, 2012-01, pp. : 1331-1335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytoreductive Surgery for Ovarian Cancer

By Omura G.A.  

Gynecologic Oncology, Vol. 80, Iss. 2, 2001-02 ,pp. : 332-332

Elsevier

Access to resources Recommend Favorite

Current Status of Primary Cytoreductive Surgery for the Treatment of Advanced Epithelial Ovarian Cancer

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 67-79

Bentham Science Publishers

Access to resources Recommend Favorite

Secondary Cytoreductive Surgery in Patients with Platinum-Sensitive Recurrent Ovarian Cancer

By Benedetti Panici Pierluigi   De Vivo Antonio   Bellati Filippo   Manci Natalina   Perniola Giorgia   Basile Stefano   Muzii Ludovico   Angioli Roberto  

Annals of Surgical Oncology, Vol. 14, Iss. 3, 2007-03 ,pp. : 1136-1142

Springer Publishing Company

Access to resources Recommend Favorite

Cytoreductive Surgery for the Management of Stage IV Ovarian Cancer

By Schwartz P.E.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian cancer

By Rutledge Teresa   Gehrig Paola  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 23-25

Informa Healthcare

Access to resources Recommend Favorite